스트라타 스킨 사이언시스(SSKN) 주가 전망 및 기업 분석 - PER·배당·실적·목표주가·RSI·MACD

🏛️

거래 정지 중인 종목 2026-06-04 이후 거래가 정지되었습니다. 재개될 수 있으며, 표시된 시세는 마지막 거래일 기준입니다.

SSKN

STRATA Skin Sciences Inc

7월 27일 4:00 PM ET (한국 7/28 05:00)

$0.19

+0.00 +0.00%

스트라타 스킨 사이언시스(SSKN) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시가총액

$1M

스몰캡

P/E

배당수익률

없음

52주 위치

저점 +5% · 고점 -95%

애널리스트

적극 매수

Fundamental health

vs. 전체 시장· based on 3 axes

수익성

산출 불가 (적자)

성장

Top 81%

밸류에이션

Top 92%

재무 안정

Top 79%

Index ⓘ	-	P/E ⓘ	-	EPS (ttm) ⓘ	-2.62	Insider Own ⓘ	33.28%	Shs Outstand ⓘ	5.3M	Perf Week ⓘ	-84.18%
Market Cap ⓘ	0.00B	Forward P/E ⓘ	-	EPS next Y ⓘ	28.33%	Insider Trans ⓘ	-0.46%	Shs Float ⓘ	3.9M	Perf Month ⓘ	-85.17%
Enterprise Value ⓘ	0.01B	PEG ⓘ	-	EPS next Q ⓘ	-0.26	Inst Own ⓘ	19.32%	Short Float ⓘ	9.13%	Perf Quarter ⓘ	-87%
Income ⓘ	-0.01B	P/S ⓘ	0.04	EPS this Y ⓘ	-648.25%	Inst Trans ⓘ	-3.07%	Short Ratio ⓘ	0.8	Perf Half Y ⓘ	-89.63%
Sales ⓘ	0.03B	P/B ⓘ	0.76	EPS next 5Y ⓘ	-	ROA ⓘ	-31.13%	Short Interest ⓘ	0.36M	Perf YTD ⓘ	-84.94%
Book/sh ⓘ	0.25	P/C ⓘ	0.16	EPS past 3/5Y ⓘ	-49.38% -17.46%	ROE ⓘ	-207.19%	52W High ⓘ	-95.08% ($3.86)	Perf Year ⓘ	-92.85%
Cash/sh ⓘ	1.2	P/FCF ⓘ	-	Sales past 3/5Y ⓘ	3.84% 1.22%	ROIC ⓘ	-71.29%	52W Low ⓘ	5.44% ($0.18)	Perf 3Y ⓘ	-98.31%
Dividend Est. ⓘ	-	EV/EBITDA ⓘ	-	EPS Y/Y TTM ⓘ	-0.81%	Gross Margin ⓘ	57.76%	Volatility(W/M) ⓘ	31.96% 14.28%	Perf 5Y ⓘ	-99.2%
Dividend TTM ⓘ	-	EV/Sales ⓘ	0.33	Sales Y/Y TTM ⓘ	-5.19%	Oper. Margin ⓘ	-20.86%	ATR (14) ⓘ	0.15	Perf 10Y ⓘ	-99.62%
Dividend Ex-Date ⓘ	-	Quick Ratio ⓘ	0.75	EPS Q/Q ⓘ	31.1%	Profit Margin ⓘ	-35.64%	RSI (14) ⓘ	17.79	Recom ⓘ	1
Dividend Gr. 3/5Y ⓘ	-	Current Ratio ⓘ	0.95	Sales Q/Q ⓘ	-21.23%	SMA20 ⓘ	-81.5% ($1.03)	Beta ⓘ	0.48	Target Price ⓘ	$10.8
Payout ⓘ	-	Debt/Eq ⓘ	12.45	Earnings ⓘ	2025/11/13	SMA50 ⓘ	-84.21% ($1.2)	Rel Volume ⓘ	0	Prev Close ⓘ	$0.19
Employees ⓘ	106	LT Debt/Eq ⓘ	10.82	EPS/Sales Surpr. ⓘ	100.79% -10.21%	SMA200 ⓘ	-89.51% ($1.81)	Avg Volume(3M) ⓘ	0.45M	Price ⓘ	$0.19
IPO ⓘ	2005/10/28	Option/Short ⓘ	No/Yes			Trades ⓘ	0	Volume ⓘ	-	Change ⓘ	-

Quarterly earnings trend Quarterly earnings data is not yet available — foreign-listed companies (ADRs) only file annual reports with the U.S., and recently listed companies may not have filed their first quarterly report.

📊 STRATA Skin Sciences Inc (SSKN) Investment Analysis

What kind of company is STRATA Skin Sciences Inc?

스트라타 스킨 사이언시스(SSKN)

Healthcare · Medical Devices

Small-Cap — Low Volume, High Volatility

🏥 STRATA Skin Sciences (SSKN) is a company specializing in aesthetic and dermatologic medical equipment that develops Xtrac excimer laser devices for the precision treatment of chronic skin conditions such as psoriasis, vitiligo, and acne, and operates a unique partnership model with a per-treatment fee structure.

Learn more about STRATA Skin Sciences Inc →

Market Cap

$0.0B

Approx. KRW 0.0 trillion

⚖️ 0% of Samsung Electronics

Market Cap Rank5852

Employees106people

IPO2005/10/28

Current Price$0.19 ≈ 260원

NASD · USA

Key Events

예정된 이벤트가 없습니다

SSKN의 다음 실적 발표일이나 배당 일정이 아직 수집되지 않았습니다.

실적 발표는 보통 분기마다 있습니다
배당주는 연 1~4회 배당락일이 있습니다

전체 경제/실적 캘린더 보기 →

Is it profitable?

Both profitability & finances need caution

Review management risk carefully before investing

Profitability — How efficiently it makes money

Operating Margin

Profit kept from selling products and services (higher is better)

-20.9%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

Net Margin

Share of revenue left after taxes and interest are paid

-35.6%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

Gross Margin

Profit after subtracting raw-material costs only (signals product competitiveness)

57.8%

✓ 양호

My positionTop 25%

Low range Average High range

전체 시장 Median 35.0% · Top 25%

💡 제조업 30%, IT/소프트웨어 50% 이상이면 우수 (업종별 편차 큼)

ROE

Annual return earned on shareholders' equity (15%+ is strong)

-207.2%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

ROA

Annual earnings relative to total company assets

-31.1%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

ROIC

Return generated per dollar invested in the business

-71.3%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

Financial health — Debt & liquidity burden

Debt-to-Equity (D/E)

Debt relative to equity (lower is healthier)

12.45

✓ Danger level

💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)

Current Ratio

Liquid assets available to cover liabilities due within a year

0.95

✓ 평균

My positionMid-range

Low range Average High range

전체 시장 Median 1.70

💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의

Quick Ratio

Liquid assets excluding inventory, available for immediate use

0.75

✓ 평균

My positionMid-range

Low range Average High range

전체 시장 Median 1.47

💡 1.0 이상이면 안전, 0.5 미만이면 주의

* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Positive Outlook

Price targets, growth, and valuation are favorable

애널리스트 목표가

$10.80

현재가 대비 +5584.2%

💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균

내년 EPS 예상 성장률

+28.3%

💡 10% 이상이면 견조한 성장, 마이너스는 이익 감소 예상

⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

Insufficient historical earnings data

No analyzable past earnings releases have been collected yet.

Is it growing?

Growth Concerns

Growth is lagging the industry average

Declining Growth EPS or revenue is declining — check for structural issues or economic sensitivity

🔮 How much will it grow? (analyst forecasts)

This Year's EPS Outlook

Projected EPS growth rate for this year

-648.3%

매우 부진

My positionBottom 5%

Low range Average High range

전체 시장 Median 15.0% · Bottom tier

Next Year's EPS Outlook

Projected EPS growth rate for next year (analyst consensus)

+28.3%

양호

My positionMid-range

Low range Average High range

전체 시장 Median 15.7% · Top 37%

📊 How much has it grown? (actual results)

Past 3-Year EPS

Actual average annual EPS growth over the past 3 years

-49.4%

매우 부진

My positionBottom 5%

Low range Average High range

전체 시장 Median 7.6% · Bottom tier

Past 5-Year EPS

Actual average annual EPS growth over the past 5 years

-17.5%

부진

My positionBottom 25%

Low range Average High range

전체 시장 Median 9.7% · Bottom 18%

Past 5-Year Revenue

How much revenue grew over the past 5 years

+1.2%

부진

My positionBottom 25%

Low range Average High range

전체 시장 Median 9.6% · Bottom 21%

⚡ Short-term momentum

QoQ Revenue

Revenue change from the previous quarter (short-term momentum)

-21.2%

부진

My positionBottom 25%

Low range Average High range

전체 시장 Median 6.5% · Bottom 13%

* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.

New to investing terms? Look it up in the financial dictionary →

Has the stock risen over the long term?

Long-term weakness — -168%p below the market

SSKN -99.2% · S&P 500 +68.4%

Excess return vs. market (price-based, ex-dividends)

5-year basis

vs S&P 500

-167.6%p

Significantly behind the market

vs Health Care (XLV)

-123.7%p

Significantly behind the sector average

1-year basis

vs S&P 500

-108.9%p

Significantly behind the market

vs Health Care (XLV)

-112.6%p

Significantly behind the sector average

Current position within 52-week range

Low (-5.4%p) High (-95.1%p)

Current price is 5.4% above the 52-week low and 95.1% below the 52-week high

Recent risk (last 21 trading days)

Max drawdown

-85.2%

Annualized volatility

433.7%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 88-day series

Price · Bollinger Bands · Ichimoku Cloud

close
BB Upper
BB Mid
BB Lower
Tenkan
Kijun
Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🔴

Current diagnosis · 2026-05-15

Downtrend zone

Current price $0.12 below the midline ($0.14). Normal downward flow. Below the Ichimoku cloud (bearish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🟡

Current diagnosis · 2026-05-15

Neutral zone — weak trend

MACD -0.020 · Signal -0.025 · Hist 0.005. Weak directional bias.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🔴

Current diagnosis · 2026-05-15

Bearish zone

RSI 40.5 (below the neutral level of 50). Selling pressure leads, indicating a weak trend. Stoch %K is also 0.0.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

Cheaper than peers in its industry

Cheap on Vs. Assets·Vs. Sales

💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.

🏢 Vs. Assets Cheap

🧾 Vs. Sales Cheap

🏢 Vs. Assets

PBR Price-to-Book Ratio

Price vs. the company's asset value — below 1 trades cheaper than assets

0.76x

✓ Very cheap

My positionTop 25%

Low range Average High range

전체 시장 median 1.76x · Top 17% — relatively cheap within the industry

💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)

🧾 Vs. Sales

PSR Price-to-Sales Ratio

Market cap vs. revenue — lower is cheaper relative to sales

0.04x

✓ Very cheap

My positionTop 5%

Low range Average High range

전체 시장 median 2.26x · Top 1% — relatively cheap within the industry

💡 PSR 2 이하 저평가, 10 초과면 고평가 (고성장 기업일 때만 정당화)

Analyst target price (reference)

$10.80 vs. current price +5584.2%

* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.

As of: Recent snapshot · Peer group: 전체 시장

Who owns it?

Ownership backdrop is unfavorable

Insider modest net selling -0.5% · Institutional net selling -3.1% · Short interest moderate 9.1% · Short interest up +1.7pp over last 21d

📈 Recent trading flow (6 months)

🧑‍💼 Insiders (executives & directors)

-0.5%

Insiders net selling

🏦 Institutions (funds & investors)

-3.1%

Institutions net selling

💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.

👥 Holdings composition

🏦 Institutions 19.3%

Retail-led

전체 시장 Median 48.6%

🧑‍💼 Insiders 33.3%

Founder/management large holders (strong skin-in-the-game)

전체 시장 Median 12.2%

👤 Retail investors (estimated) 47.4%

Everyone excluding institutions and insiders

Institutions Insiders Retail (est.)

📉 Short-selling metrics

Short ratio

9.1%

Moderate

전체 시장 Median 4.0%

Past 21 days 📈 +1.7%p increase

Short interest days to cover

0.8 days

Days needed to close short positions using average trading volume

🧮 Share count

Total shares outstanding 5.3M주

Float (tradable shares) 3.9M주

* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 21 days.

How much does it pay in dividends?

This company does not pay a dividend

It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)

Sorted by market cap, largest first

Stock	Market Cap	PER	PBR	ROE	Dividend Yield	Change
SSKN This Stock	$1.1M	-	0.8 ▲	-207.19% ▼	-	+0.0%
LLY	$1.13T	43.1 ▼	36.2 ▼	107.64% ▲	0.58% ▼	+0.1%
JNJ	$640.9B	30.8 ▼	7.5 ▼	25.74% ▲	2.02% ▲	+1.0%
ABBV	$453.9B	126.7 ▼	-	15221.82% ▲	2.67% ▲	-0.9%
UNH	$379.3B	26.9 ▼	3.9 ▼	12.49% ▲	2.16% ▲	-0.7%
MRK	$323.0B	36.8 ▼	7.0 ▼	18.97% ▲	2.5% ▲	-0.2%
Sector Avg	-	26.1	2.7	-48.83%	1.23%	-

FAQ

What kind of company is 스트라타 스킨 사이언시스(SSKN)?

스트라타 스킨 사이언시스(SSKN) belongs to the Healthcare sector and operates in the Medical Devices industry.

What is the market cap of SSKN?

The market cap of SSKN is approximately $1M, ranking 5,852 within its sector.

What is the 52-week high and low for SSKN?

SSKN has recorded a 52-week high of $3.86 and a low of $0.18.

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.